AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,995 | -7.3% | 243,134 | 0.0% | 0.32% | -1.9% |
| Q2 2023 | $401,171 | +44.7% | 243,134 | 0.0% | 0.32% | +30.1% |
| Q1 2023 | $277,173 | +26.4% | 243,134 | 0.0% | 0.25% | +39.1% |
| Q4 2022 | $219,331 | -22.8% | 243,134 | 0.0% | 0.18% | -21.8% |
| Q3 2022 | $284,000 | +82.1% | 243,134 | 0.0% | 0.23% | +78.9% |
| Q2 2022 | $156,000 | -75.4% | 243,134 | 0.0% | 0.13% | -69.0% |
| Q1 2022 | $635,000 | -32.9% | 243,134 | 0.0% | 0.41% | -29.4% |
| Q4 2021 | $946,000 | -10.8% | 243,134 | 0.0% | 0.58% | -11.6% |
| Q3 2021 | $1,060,000 | +9.8% | 243,134 | 0.0% | 0.66% | +8.2% |
| Q2 2021 | $965,000 | – | 243,134 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |